Alpa Laboratories Limited (BOM:532878)
67.88
-0.97 (-1.41%)
At close: Jun 19, 2026
Alpa Laboratories Revenue
In the fiscal year ending March 31, 2026, Alpa Laboratories had annual revenue of 1.06B INR, down -5.91%. Alpa Laboratories had revenue of 313.96M in the quarter ending March 31, 2026, a decrease of -21.35%.
Revenue
1.06B
Revenue Growth
-5.91%
P/S Ratio
1.35
Revenue / Employee
2.34M
Employees
453
Market Cap
1.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.06B | -66.42M | -5.91% |
| Mar 31, 2025 | 1.12B | 37.13M | 3.41% |
| Mar 31, 2024 | 1.09B | 157.84M | 16.98% |
| Mar 31, 2023 | 929.55M | -193.11M | -17.20% |
| Mar 31, 2022 | 1.12B | 147.12M | 15.08% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.34B |
| Bal Pharma | 3.12B |
| Parnax Lab | 2.49B |
| Lactose (India) | 1.63B |
| Aayush Wellness | 1.55B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |
| Speciality Medicines | 761.14M |